Carregant...
The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
There is a global obesity epidemic that will continue to be a financial burden on healthcare systems around the world. Tackling obesity through diet and exercise should always be the first intervention, but this has not proved to be effective for a large number of patients. Pharmacotherapeutic optio...
Guardat en:
| Publicat a: | Ther Adv Chronic Dis |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772342/ https://ncbi.nlm.nih.gov/pubmed/26977279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622315620180 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|